A phase I/II study of osimertinib in EGFR exon 20 insertion mutation-positive non-small cell lung cancer

Hiroyuki Yasuda, Eiki Ichihara, Jun Sakakibara-Konishi, Yoshitaka Zenke, Shinji Takeuchi, Masahiro Morise, Katsuyuki Hotta, Mineyoshi Sato, Shingo Matsumoto, Azusa Tanimoto, Reiko Matsuzawa, Katuyuki Kiura, Yuta Takashima, Seiji Yano, Junji Koyama, Takahiro Fukushima, Junko Hamamoto, Hideki Terai, Shinnosuke Ikemura, Ryo TakemuraKoichi Goto, Kenzo Soejima

Research output: Contribution to journalArticlepeer-review

18 Citations (Scopus)

Fingerprint

Dive into the research topics of 'A phase I/II study of osimertinib in EGFR exon 20 insertion mutation-positive non-small cell lung cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences